|
|
|
|
Resident-Performed Ahmed Glaucoma Valve Surgery
OPHTHALMIC SURGERY, LASERS AND IMAGING Vol.41 No. 2 March/ 2010 Resident-Performed Ahmed Glaucoma Valve Surgery Rajen U. Desai, MD; Melike Pekmezci, MD; Diamond Tam, MD; Julia Song, MD; Shan C. Lin, MD BACKGROUND AND OBJECTIVE To evaluate the...
|
|
|
Host of New Products from Muller at POWTECH
A variety of new products from Mller GmbH can be seen at POWTECH 2010 (27th29th April, Nrnberg, Germany) Hall 9, Stand 316.This year there will be lots of new products on display. Mller will present its new generation of mobile drum lifters. The companys...
|
|
|
EVEREST II trail shows Abbott's MitraClip system has potential to treat patients with mitral regurgitation
Late-breaking data presented at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that Abbott's investigational MitraClip system met both its...
|
|
|
International Study of Transcatheter Aortic Valve System Launched
Several new initiatives in a robust international clinical program for a transcatheter aortic valve system have been set in motion with the goal of expanding the evidence base for the future of structural heart disease therapy.Medtronic, Inc.
|
|
|
Medtronic Starts International Study Of CoreValve Transcatheter Aortic Valve System
Moving to expand the evidence base for the future of structural heart disease therapy,Medtronic, Inc.(NYSE: MDT), today announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve...
|
|
|
Testing Transcatheter Heart Valve Devices
Implementing and conducting a robust and efficient in vitro test validation protocol for transcatheter heart valve devices is complex.This article proposes a method to reduce cost and to optimise the development cycle of these products. Lack of...
|
|
|
Solenoid Valve from Bert Convinces in 3/2 and 2/2 Way Version
With the media separated 6650 flipper valve, Brkert presents an extremely compact, fast switching valve which has been optimised especially for reproducible and precise dosing of aggressive fluids.In addition to a 2/2 way version with a nominal diameter of 0...
|
|
|
Abbott's Heart Valve Device Proves Safe, Effective
An experimental, minimally invasive technique to repair the most common type of heart valve problem proved to be far safer and nearly as effective as open heart surgery, meeting the primary goals of a pivotal study, researchers said on Sunday.
|
|
|
"Clothespin" Like Clip Insertion to Repair Faulty Mitral Heart Valve
Heart Disease News Font Size Print Comments According to a new study released Sunday, inserting a clip resembling a clothespin into the heart can help doctors efficiently repair a defective mitral valve.In the procedure which does not involve any...
|
|
|
Mitral regurgitation: MitraClip safe, effective alternative option to open heart surgery
NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented data today at the American College of Cardiology annual scientific sessions from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy)...
|
|
|
EVEREST II Trial Data Suggests Promise of Investigational Mitral Valve Repair Device
Late-breaking data presented at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial suggests that an investigational minimally invasive mitral repair device...
|
|
|
ACC: MitraClip system may present alternative for non-surgical patients
ATLANTAThe MitraClip system, a catheter-mounted device that acts like a clothespin to clip together the flaps of a leaky mitral valve, is a safe and effective alternative to open-heart surgery in selected patients with mitral regurgitation, according to...
|
|
|
New Data Demonstrates Abbott's Investigational MitraClip System Has Potential to be a Valuable Treatment Option for Patients with Mitral Regurgitation, the Most Common Heart Valve Condition
Latebreaking data presented at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II trial demonstrated that Abbott's investigational MitraClip system met both its primary safety and effectiveness New Data Demonstrates...
|
|
|
Clip Device for Mitral Regurgitation Just as Effective as Surgery, with Improved Safety
ATLANTA, GAMitral valve repair with a percutaneously delivered clip treats mitral regurgitation (MR) just as effectively as open surgery, and with lower rates of death, stroke, and other adverse events, according to data presented during a late breaking trial...
|
|
|
Three-Dimensional Echocardiography and Mitral Valve Disease
Chapman CB et al.Threedimensional echocardiography has the ability to help guide operative and percutaneous interventions, allowing for improved patient outcomes and advancement of clinical research. Three-Dimensional Echocardiography and Mitral Valve...
|
|
|
Medtronic Starts International Study of CoreValve Transcatheter Aortic Valve System
_ Medtronic Starts International Study of CoreValve Transcatheter Aortic Valve System.
|
|
|
Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients
Companies mentioned in this article: NorthShore University HealthSystem EVANSTON, Ill., March 14 /PRNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented data today at the American College of...
|
|
|
New Data Demonstrates Abbott's Investigational MitraClip(R)
Abbott Laboratories (ABT) Stock Quote, Chart, News, Add to Watchlist All PR Newswire news System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition - First-of-its-Kind,...
|
|
|
Abbott's MitraClip Heart Valve Repair Device Meets Primary Safety, Effectiveness Goals
3/14/2010 9:30 AM ET RELATED NEWS Trade ABT now with TOP MARKET NEWS (RTTNews) - Healthcare company Abbott Laboratories (ABT: News ) Sunday said its Endovascular Valve Edge-to-Edge REpair Study, or EVEREST II, trial showed that the company's MitraClip...
|
|
|
New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
Companies mentioned in this article: Abbott ATLANTA, March 14 /PRNewswire-FirstCall/ -- Late-breaking data presented today at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge...
|
|
|
Abbott Heart Valve-repair Tool Meets Goals In Key Study
ATLANTA -(Dow Jones)- An Abbott Laboratories (ABT) device designed to improve a leaky heart valve without major surgery met its safety and effectiveness goals in a key study released Sunday.Abbott hopes to win Food and Drug Administration approval to...
|
|
|
Abbott Heart Valve-Repair Tool Meets Goals In Key Study
ATLANTA -(Dow Jones)- An Abbott Laboratories (ABT) device designed to improve a leaky heart valve without major surgery met its safety and effectiveness goals in a key study released Sunday.Abbott hopes to win Food and Drug Administration approval to...
|
|
|
Abbott Heart Valve-Repair Tool Meets Goals In Key Study
ATLANTA -(Dow Jones)- An Abbott Laboratories (ABT) device designed to improve a leaky heart valve without major surgery met its safety and effectiveness goals in a key study released Sunday.Abbott hopes to win Food and Drug Administration approval to...
|
|
|
Abbott Heart Valve-Repair Tool Meets Goals In Key Study
ATLANTA -(Dow Jones)- An Abbott Laboratories (ABT) device designed to improve a leaky heart valve without major surgery met its safety and effectiveness goals in a key study released Sunday.Abbott hopes to win Food and Drug Administration approval to...
|
|
|
Abbott Heart Valve-Repair Tool Meets Goals In Key Study
ATLANTA -(Dow Jones)- An Abbott Laboratories (ABT) device designed to improve a leaky heart valve without major surgery met its safety and effectiveness goals in a key study released Sunday.Abbott hopes to win Food and Drug Administration approval to...
|
